| Literature DB >> 32397357 |
Dorota Formanowicz1, Agnieszka Rybarczyk2,3, Marcin Radom2,3, Piotr Formanowicz2,3.
Abstract
Recent studies have shown that the innate and adaptive immune system, together with low-grade inflammation, may play an important role in essential hypertension. In this work, to verify the importance of selected factors for the development of essential hypertension, we created a Petri net-based model and analyzed it. The analysis was based mainly on t-invariants, knockouts of selected fragments of the net and its simulations. The blockade of the renin-angiotensin (RAA) system revealed that the most significant effect on the emergence of essential hypertension has RAA activation. This blockade affects: (1) the formation of angiotensin II, (2) inflammatory process (by influencing C-reactive protein (CRP)), (3) the initiation of blood coagulation, (4) bradykinin generation via the kallikrein-kinin system, (5) activation of lymphocytes in hypertension, (6) the participation of TNF alpha in the activation of the acute phase response, and (7) activation of NADPH oxidase-a key enzyme of oxidative stress. On the other hand, we found that the blockade of the activation of the RAA system may not eliminate hypertension that can occur due to disturbances associated with the osmotically independent binding of Na in the interstitium. Moreover, we revealed that inflammation alone is not enough to trigger primary hypertension, but it can coexist with it. We believe that our research may contribute to a better understanding of the pathology of hypertension. It can help identify potential subprocesses, which blocking will allow better control of essential hypertension.Entities:
Keywords: Petri nets; hypertension; immunological phenomena; inflammation; mathematical modeling; t-invariants
Mesh:
Substances:
Year: 2020 PMID: 32397357 PMCID: PMC7247551 DOI: 10.3390/ijms21093348
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The general working scheme describing the steps that should be taken in order to create model, conduct the analysis and obtain results.
Figure 2Example results of t-invariants knockout (left) and simulation knockout (right). In the left picture and (in blue) belong to the same MCT as , while transitions covered in black are knocked out. Only and remained active, i.e., they are in the support of unaffected t-invariant. In the right picture the area colored in red do not function due to lack of tokens in caused by knockout. Other transitions still work and their average firing is given as a value above them. For working places the filling of a small bar represent total accumulation of their tokens in the simulation.
The list of places of the model.
| Place | Biological Meaning | References | Place | Biological Meaning | References |
|---|---|---|---|---|---|
|
| angiotensinogen | [ |
| T lymphocytes in adventitia and perivascular adipose tissue | [ |
|
| angiotensin I | [ |
| bradykinin and BR1 complex | [ |
|
| high angiotensin II | [ |
| BR1 | [ |
|
| ACE on vascular endothelium | [ |
| bradykinin | [ |
|
| BR2 in EC | [ |
| bradykinin and B2R complex | [ |
|
| TNF alpha | [ |
| VEGF-C | [ |
|
| AT1R | [ |
| kalikrein | [ |
|
| ET1 | [ |
| XII factor | [ |
|
| C-reactive protein (CRP) | [ |
| HMWK with zinc | [ |
|
| prorenin-renin axis | [ |
| damaged endothelium with platelets aggregation | [ |
|
| high PGI2 | [ |
| IL-17 | [ |
|
| lower blood pressure | [ |
| increase in IFN gamma | [ |
|
| T lymphocytes | [ |
| TNFR1 | [ |
|
| APC (macrophages, lymphocytes B and dendritic cells) | [ |
| TNF alpha-TNFR1 complex | [ |
|
| APC cells with neoantigens | [ |
| shear stress | [ |
|
| neoantigens | [ |
| Na bound to glycosaminoglycans in interstitium | [ |
|
| superoxide anion | [ |
| AT2R | [ |
|
| high blood pressure | [ |
| attracted MPS | [ |
|
| NADPH oxidase activated | [ |
| TonEBP | [ |
|
| low NO | [ |
| VEGF-C and VEGFR3 complex | [ |
|
| low eNOS coupled | [ |
| VEGFR3 | [ |
|
| ADMA | [ |
| VEGF-C and VEGFR2 complex | [ |
|
| eNOS uncoupled | [ |
| high eNOS coupled | [ |
|
| Th lymphocytes | [ |
| high NO | [ |
|
| CCR5 | [ |
| VEGFR2 | [ |
|
| RANTES | [ |
| peroxynitrite (ONOO anion) | [ |
The list of transitions of the model.
| Transition | Biological Meaning | References | Transition | Biological Meaning | References |
|---|---|---|---|---|---|
|
| angiotensinogen synthesis | [ |
| IFN gamma synthesis as response for LPS | [ |
|
| angiotensinogen with renin binding | [ |
| TNF alpha with TNFR1 binding | [ |
|
| angiotensin I with ACE binding | [ |
| TNFR1 expression | [ |
|
| NADPH oxidase activation via AT1R | [ |
| acute phase reaction | [ |
|
| ACE influenced by BR2 | [ |
| increase in neoantigens formation | [ |
|
| ACE synthesis by vascular endothelium | [ |
| neoantigens formation | [ |
|
| ACE influenced by TNF alpha | [ |
| neoantigens formation under shear stress | [ |
|
| synthesis and stimulation of ET1 release | [ |
| shear stress influenced by high blood pressure | [ |
|
| stimulation of prorenin-renin axis caused by PGI2 and PGE2 | [ |
| reducing the activity of eNOS by CRP | [ |
|
| sympathetic stimulation under stress | [ |
| reduction of the bioavailability of NO | [ |
|
| decrease in renal perfussion | [ |
| vasoconstriction | [ |
|
| T lymphocytes activation and proliferation via AT1R | [ |
| hypertension | [ |
|
| the immune system activation via inflammation | [ |
| blood pressure increasing | [ |
|
| APC with neoantigens binding | [ |
| induction of Th 17 | [ |
|
| AT1R source | [ |
| osmotically independent binding of Na in interstitium | [ |
|
| increased AT1R at vascular smooth muscles | [ |
| AT2R expression | [ |
|
| superoxide anion generation via high blood pressure | [ |
| AT2R mediated PGI2 production by endothelial cells | [ |
|
| superoxide anion generation via NADPH oxidase | [ |
| synthesis of PGI2 by endothelial cells | [ |
|
| superoxide anion generation via low NO | [ |
| lowering blood pressure by PGI2 | [ |
|
| decreased NO synthesis by endothelial cells | [ |
| the immune system activation in interstitium under local hypertonic state | [ |
|
| eNOS expression significantly attenuated by TNF alpha | [ |
| TonEBP synthesis under local hypertonic state | [ |
|
| induction of ADAMA synthesis by oxidative stress | [ |
| VEGF-C activation | [ |
|
| eNOS expression significantly attenuated by ADMA | [ |
| VEGF-C with VEGFR3 binding | [ |
|
| early hypertension or kidney disease | [ |
| modification of lymph capillary network via VEGFR3 | [ |
|
| eNOS uncoupled formation | [ |
| process in lymphatic endothelium | [ |
|
| migration of Th lymphocytes into the blood vessels | [ |
| VEGF-C with VEGFR2 binding (canonical signaling) | [ |
|
| increased expression of CCR5 | [ |
| eNOS synthesis induction, calcium and phosphorylation dependent | [ |
|
| RANTES influenced by TNF-TNFR axis | [ |
| NO increase | [ |
|
| ICAM1, VCAM1 and PECAM endothelial stimulation | [ |
| muscles relaxation | [ |
|
| bradykinin with BR1 binding | [ |
| health | [ |
|
| bradykinin with BR2R binding | [ |
| NADPH oxidase activation via VEGFR2 | [ |
|
| stimulation of VEGF-C formation by bradykinin-B2R complex | [ |
| vascular endothelium VEGFR2 expression | [ |
|
| bradykinin formation | [ |
| VEGF pathway (ligand independent, non canonical signaling) | [ |
|
| prekalikrein and kalikrein formation | [ |
| peroxynitrite (ONOO anion) formation | [ |
|
| increase in HMWK with zinc and XII factor | [ |
| oxidation of BH4 (eNOS cofactor) | [ |
|
| chronic inflammatory process | [ |
| superoxide anion synthesis by eNOS uncoupling | [ |
|
| the local release of cytokines (local inflammation) | [ |
| low NO synthesis | [ |
Figure 3The diagram of the role of inflammation and immunity in essential hypertension. The orange blocks represent known factors affecting primary hypertension. Gray blocks include processes/factors whose involvement in hypertension is increasingly recognized.
Figure 4The Petri net based model. Non-trivial Maximal Common Transition (MCT) sets are marked by accordingly labeled rectangles. The transitions within a given MCT sets are shown with different colors. Logical places are shown as two concentric circles and are denoted by their names. The places and transitions are represented by both their names and numbers.
The list of non-trivial MCT sets.
| MCT-Set | Contained Transitions | Biological Interpretation |
|---|---|---|
|
| The initiation of blood coagulation, and the generation of bradykinin via the kallikrein-kinin system | |
|
| Lymphocytes T activation in hypertension—as a part of immune system defense | |
|
| The participation of TNF alpha in the activation of the acute phase response in the course of hypertension | |
|
| Impact of VEGF-C—VEGFR2 axis on the nitric oxide synthesis and relaxation of vascular smooth muscles | |
|
| Angiotensinogen-angiotensin axis activation leading to angiotensin II formation | |
|
| Local activation of the immune system due to changes in the local hypertonia associated with the activation of VEGF-C | |
|
| Impact of the VEGF-C—VEGFR3 axis on the lymphatic endothelium | |
|
| Activation of key enzymes of oxidative stress (NADPH oxidases) through AT1R | |
|
| The influence of shear stress on the formation of neoantigens and increased arterial blood pressure | |
|
| Peroxynitrite formation as a part of oxidative stress signaling pathway |
The 2588 feasible t-invariants of the model clustered by Unweighted Pair Group Method with Arithmetic Mean (UPGMA) algorithm. In the two columns on the right side of the table, the processes contained in the clusters are listed. Processes are divided into non-trivial MCT sets and single transitions. The numbers presented in brackets are fractions (a number of supports of t-invariants from a given t-clusters containing a given process)/(a number of supports of t-invariants from all other t-clusters containing a given process)%. The lack of any number means that a given transition or MCT-set occurs only in supports of t-invariants being elements of a given t-cluster. The columns on the left side give the total number of t-invariants in the cluster, together with its biological interpretation.
| Cluster No. | Biological Interpretation | No. of t-Invariants | Contained Processes | |
|---|---|---|---|---|
| MCT-Sets | Single Transitions | |||
|
| The local changes in the interstitium due to fluctuations in the local independent osmotic sodium concentration | 1 |
| |
|
| Formation and effects of reactive oxygen species on hypertension | 4 |
| |
|
| Processes mediated by PGI2, resulting in the reduction of blood pressure and maintenance of health state | 2 | ||
|
| The influence of oxidative stress and inflammation on vascular endothelium in the course of arterial hypertension without changes regarding the lymphatic endothelium | 2572 | ||
|
| Processes leading to hypertension, with particular emphasis on the role of IL-17 | 2 | ||
|
| Processes leading to hypertension, with particular emphasis on the effect of nitric oxide, the role of ADMA and VEGFR2 | 7 | ||
The most important activities in the model according to their combinatorial knockout impact calculated based on both simulation knockout and the approach described in [23]. In the calculation of the knockout impact in the case of transitions, only the inactive ones, according to simulation knockout, were taken into account.
| MCT-Set | Activity | Knockout Impact | Knockout Impact |
|---|---|---|---|
|
| ACE synthesis by vascular endothelium | 33.78% | 99.73% |
|
| angiotesinogen-angiotensin axis activation leading to angiotensin II formation | 28.38% | 99.34% |
|
| AT1R source | 31.08% | 99.23% |
|
| the influence of shear stress on the formation of neoantigens and increased arterial blood pressure | 31.08% | 99.23% |
|
| lymphocytes T activation in hypertension as a part of immune system defense | 27.03% | 98.92% |
|
| AT2R expression | 22.97% | 97.68% |
|
| blood pressure increasing | 0.00% | 96.87% |
|
| the participation TNF alpha in the activation of the acute phase response in the course of hypertension | 22.97% | 96.79% |
|
| the initiation of blood coagulation, and the generation of bradykinin via the kallikrein-kinin system | 0.00% | 92.39% |
|
| ACE influenced by BR2 | 0.00% | 88.79% |
|
| vascular endothelium VEGFR2 expression | 8.11% | 74.03% |
|
| hypertension | 0.00% | 68.47% |
|
| impact of the VEGF-C—VEGFR2 axis on the nitric oxide synthesis and relaxation of vascular smooth muscles | 0.00% | 55.91% |
|
| IFN gamma synthesis as response for LPS | 0.00% | 53.40% |
|
| decrease in renal perfussion | 0.00% | 50.50% |
|
| increased AT1R at vascular smooth muscles | 0.00% | 43.51% |
|
| vasoconstriction | 0.00% | 39.26% |
|
| impact of the VEGF-C—VEGFR3 axis on the lymphatic endothelium | 0.00% | 38.68% |
|
| stimulation of prorenin-renin axis caused by PGI2 and PGE2 | 0.00% | 38.25% |
|
| superoxide anion generation via high blood pressure | 0.00% | 36.51% |
|
| superoxide anion generation via low NO | 0.00% | 36.40% |
|
| eNOS uncoupled formation | 0.00% | 34.47% |
|
| reducing the activity of eNOS by CRP | 0.00% | 31.72% |
|
| VEGF pathway (ligand independent, non canonical signaling) | 0.00% | 31.11% |
|
| AT2R mediated PGI2 production by endothelial cells | 0.00% | 30.80% |
|
| synthesis of PGI2 by endothelial cells | 0.00% | 30.80% |
|
| superoxide anion generation via NADPH oxidase | 0.00% | 29.02% |
|
| early hypertension or kidney disease | 0.00% | 27.13% |
|
| ACE influenced by TNF alpha | 0.00% | 25.70% |
|
| health | 0.00% | 23.76% |
|
| lowering blood pressure by PGI2 | 0.00% | 23.34% |
|
| neoantigens formation | 0.00% | 23.18% |
|
| increase in neoantigens formation | 0.00% | 19.36% |
|
| low NO synthesis | 0.00% | 19.32% |
|
| reduced bioavailability of NO | 0.00% | 19.24% |
|
| activation of a key enzymes of oxidative stress (NADPH oxidases) through AT1R | 0.00% | 19.13% |
|
| sympathetic stimulation under stress | 0.00% | 19.13% |
|
| superoxide anion synthesis by eNOS uncoupling | 0.00% | 16.27% |
|
| decreased NO synthesis by endothelial cells | 0.00% | 15.19% |
|
| induction of ADAMA synthesis by oxidative stress | 0.00% | 12.94% |
|
| NADPH oxidase activation via VEGFR2 | 0.00% | 10.01% |
|
| eNOS expression significantly attenuated by TNF alpha | 0.00% | 9.81% |
|
| eNOS expression significantly attenuated by ADMA | 0.00% | 5.64% |
|
| osmotically independent binding of Na in interstitium | 5.41% | 4.48% |
|
| local activation of the immune system due to changes in the local hypertonia associated with an activation of VEGF-C | 0.00% | 4.21% |
|
| peroxynitrite formation as a part of an oxidative stress signaling pathway | 0.00% | 1.16% |
|
| induction of Th 17 | 0.00% | 0.31% |
Figure 5Graphical representation of the knockout results for the entire model, upon disabling of the transitions belonging to . Inactive transitions, according to the simulation knockout, are marked with red circles. Active transitions are marked with rectangles filled with green or orange color which indicates whether the activity of a given transition has decreased (partially filled) or stayed intact (fully filled) as compared to the reference set. The results were obtained using Holmes software [41].
The impact of knockout. The columns on the right side of the table present each transition activity before and after the knockout of transitions belonging to . The change in the activity in the case of each transition is shown in the last column. A positive value means that a given transition activity has increased while the negative one indicates that the transition activity has decreased. The transitions that were manually disabled are denoted as “(Offline)”. Those indicated by the simulation knockout as inactive due to knockout are marked as “(Knockout)”. Each entry in the table corresponds to the average value coming from 4000 simulation runs, each having 10,000 steps.
| Transition | Biological Meaning | The Transition Activity in the Reference Set | The Transition Activity in the Set with | Difference in the Transition Activity as Compared to the Reference and |
|---|---|---|---|---|
|
| (Offline) angiotensinogen synthesis | 50.00% | 0.00% | −50.00% |
|
| (Offline) angiotensinogen with renin binding | 49.44% | 0.00% | −49.44% |
|
| (Offline) angiotensin I with ACE binding | 49.05% | 0.00% | −49.05% |
|
| (Knockout) NADPH oxidase activation via AT1R | 0.60% | 0.00% | −0.60% |
|
| (Knockout) ACE influenced by BR2 | 2.51% | 0.00% | −2.51% |
|
| ACE synthesis by vascular endothelium | 50.00% | 50.00% | 0.00% |
|
| (Knockout) ACE influenced by TNF alpha | 3.50% | 0.00% | −3.50% |
|
| (Knockout) synthesis and stimulation of ET1 release | 0.63% | 0.00% | −0.63% |
|
| stimulation of prorenin-renin axis caused by PGI2 and PGE2 | 48.32% | 49.41% | 1.09% |
|
| sympathetic stimulation under stress | 49.98% | 49.99% | 0.01% |
|
| decrease in renal perfussion | 27.82% | 28.45% | 0.63% |
|
| (Knockout) T lymphocytes activation and proliferation via AT1R | 12.21% | 0.00% | −12.21% |
|
| the immune system activation via inflammation | 50.00% | 50.01% | 0.01% |
|
| APC with neoantigens binding | 30.87% | 19.04% | −11.83% |
|
| AT1R source | 50.01% | 50.01% | 0.00% |
|
| (Knockout) increased AT1R at vascular smooth muscles | 0.62% | 0.00% | −0.62% |
|
| superoxide anion generation via high blood pressure | 26.84% | 19.06% | −7.79% |
|
| superoxide anion generation via NADPH oxidase | 26.55% | 27.67% | 1.12% |
|
| superoxide anion generation via NADPH oxidase | 26.55% | 27.67% | 1.12% |
|
| superoxide anion generation via low NO | 43.17% | 32.21% | −10.96% |
|
| decreased NO synthesis by EC | 49.85% | 49.42% | −0.43% |
|
| (Knockout) eNOS expression significantly attenuated by TNF alpha | 2.31% | 0.00% | −2.31% |
|
| induction of ADMA synthesis by oxidative stress | 35.15% | 30.04% | −5.11% |
|
| eNOS expression significantly attenuated by ADMA | 49.97% | 49.98% | 0.02% |
|
| early hypertension or kidney disease | 50.01% | 49.99% | −0.02% |
|
| (Knockout) eNOS uncoupled formation | 12.22% | 0.00% | −12.22% |
|
| (Knockout) migration of Th lymphocytes into the blood vessels | 11.80% | 0.00% | −11.80% |
|
| increased expression of CCR5 | 50.00% | 50.00% | 0.00% |
|
| RANTES influenced by TNF-TNFR axis | 50.00% | 50.00% | 0.01% |
|
| (Knockout) ICAM1, VCAM1 and PECAM endothelial stimulation | 0.62% | 0.00% | −0.62% |
|
| (Knockout) bradykinin with BR1 binding | 0.62% | 0.00% | −0.62% |
|
| (Knockout) bradykinin with BR2R binding | 0.62% | 0.00% | −0.62% |
|
| (Knockout) stimulation VEGF-C formation by bradykinin-B2R complex | 0.62% | 0.00% | −0.62% |
|
| (Knockout) bradykinin formation | 0.62% | 0.00% | −0.62% |
|
| (Knockout) prekalikrein and kalikrein formation | 0.62% | 0.00% | −0.62% |
|
| (Knockout) increase in HMWK with zinc and XII factor | 0.62% | 0.00% | −0.62% |
|
| (Knockout) chronic inflammatory process | 0.62% | 0.00% | −0.62% |
|
| (Knockout) the local release of cytokines (local inflammation) | 12.42% | 0.00% | −12.42% |
|
| IFN gamma synthesis as response for LPS | 49.99% | 50.01% | 0.02% |
|
| (Knockout) TNF alpha with TNFR1 binding | 3.13% | 0.00% | −3.13% |
|
| TNFR1 expression | 50.00% | 49.99% | −0.01% |
|
| (Knockout) acute phase reaction in the liver | 3.13% | 0.00% | −3.13% |
|
| (Knockout) increase in neoantigens formation | 0.63% | 0.00% | −0.63% |
|
| (Knockout) neoantigens formation | 3.50% | 0.00% | −3.50% |
|
| neoantigens formation under shear stress | 26.83% | 19.06% | −7.78% |
|
| shear stress influenced by high blood pressure | 26.84% | 19.06% | −7.78% |
|
| (Knockout) reducing the activity of eNOS by CRP | 0.62% | 0.00% | −0.62% |
|
| (Knockout) reduced bioavailability of NO | 12.22% | 0.00% | −12.22% |
|
| vasoconstriction | 43.15% | 32.20% | −10.95% |
|
| hypertension | 26.85% | 19.06% | −7.79% |
|
| blood pressure increasing | 37.40% | 24.99% | −12.41% |
|
| induction of Th 17 | 25.00% | 24.99% | 0.00% |
|
| osmotically independent binding of Na in interstitium | 50.00% | 50.00% | 0.00% |
|
| AT2R expression | 49.99% | 50.00% | 0.01% |
|
| AT2R mediated PGI2 production by endothelial cells | 46.79% | 49.44% | 2.65% |
|
| synthesis of PGI2 by endothelial cells | 50.00% | 50.01% | 0.00% |
|
| lowering blood pressure by PGI2 | 48.32% | 49.42% | 1.10% |
|
| the immune system activation in interstitium under local hypertonic state | 25.00% | 25.00% | 0.00% |
|
| TonEBP synthesis under local hypertonic state | 24.99% | 24.99% | 0.00% |
|
| VEGF-C activation | 24.98% | 24.98% | 0.00% |
|
| VEGF-C with VEGFR3 binding | 18.28% | 17.48% | −0.80% |
|
| modification of lymph capillary network via VEGFR3 | 18.27% | 17.48% | −0.80% |
|
| process in lymphatic endothelium | 50.00% | 50.00% | −0.01% |
|
| VEGF-C with VEGFR2 binding (canonical signaling) | 7.32% | 7.50% | 0.18% |
|
| eNOS synthesis induction calcium and phosphorylation dependent | 7.32% | 7.50% | 0.18% |
|
| NO increase | 7.32% | 7.50% | 0.18% |
|
| muscles relaxation | 7.32% | 7.49% | 0.18% |
|
| health | 27.80% | 28.46% | 0.65% |
|
| NADPH oxidase activation via VEGFR2 | 25.95% | 27.68% | 1.72% |
|
| vascular endothelium VEGFR2 expression | 50.01% | 50.00% | −0.01% |
|
| VEGF pathway (ligand independent, non canonical signaling) | 16.73% | 14.81% | −1.91% |
|
| peroxynitrire (ONOO anion) formation | 35.16% | 30.04% | −5.11% |
|
| oxidation of BH4 (eNOS cofactor) | 35.14% | 30.03% | −5.11% |
|
| superoxide anion synthesis by eNOS uncoupling | 23.68% | 15.02% | −8.67% |
|
| low NO synthesis | 23.67% | 15.01% | −8.65% |
The list of places that will not carry any tokens during simulation as the effect of the knockout.
| Place | Biological Meaning |
|---|---|
|
| angiotensinogen |
|
| angiotensin I |
|
| high angiotensin II |
|
| BR2 in EC |
|
| TNF alpha |
|
| ET1 |
|
| C-reactive protein (CRP) |
|
| Th lymphocytes |
|
| T lymphocytes in adventitia and perivascular adipose tissue |
|
| bradykinin and BR1 complex |
|
| BR1 |
|
| bradykinin |
|
| kalikrein |
|
| XII factor |
|
| HMWK with zinc |
|
| damaged endothelium with platelet aggregation |
|
| TNF alpha-TNFR1 complex |
The impact of each MCT set knockout on the net according to the simulation knockout.
| MCT Set Knocked out | MCT Sets Whose Transitions Are Inactive |
|---|---|
| According to the Simulation Knockout | |
|
| - |
|
| |
|
| |
|
| - |
|
| |
|
| - |
|
| - |
|
| - |
|
| |
|
| - |
Figure 6Graphical representation of the knockout impact of the transitions belonging to —one of the two remaining t-invariants whose supports contain transition (a post-place of is corresponding to IL-17). Inactive transitions, according to the simulation knockout, are denoted with a crossed out black circles. Transitions belonging to the support of the t-invariant are marked with filled green rectangles. The results were obtained using Holmes software [41].
Figure 7Graphical representation of the knockout impact of the transitions belonging to —the second of the two remaining t-invariants whose supports contain transition (a post-place of is corresponding to IL-17). Inactive transitions, according to the simulation knockout, are denoted with a crossed out black circles. Transitions belonging to the support of the t-invariant are marked with filled green rectangles. The results were obtained using Holmes software [41].
Figure 8Graphical representation of the t-invariant corresponding to VEGF-C pathway. Transitions belonging to the support of the t-invariant are marked with filled green rectangles. The results were obtained using Holmes software [41].
Figure 9Graphical representation of the knockout results for the entire model, upon disabling of the transitions , , and those belonging to . Inactive transitions, according to the simulation knockout, are marked with red circles. Active transitions are marked with rectangles filled with green or orange color which indicates whether the activity of a given transition has decreased (partially filled) or stayed intact (fully filled) as compared to the reference set. The results were obtained using Holmes software [41].